Skip to main content

Featured Videos | view more

Advances in Immunotherapy for Pancreatic Cancer: Robert H. Vonderheide, MD, DPhil (Part 1) Video

Advances in Immunotherapy for Pancreatic Cancer: Robert H. Vonderheide, MD, DPhil (Part 1)

Dr. Robert H. Vonderheide, Director of the Abramson Cancer Center at Penn Medicine, reviews the triumphs and challenges of cancer therapy over the last quarter century, focusing on new tools and the motivation driving the focus on immunotherapy ...

Best Practices for Telemedicine: The Provider and Patient Experience | Penn Medicine Video

Best Practices for Telemedicine: The Provider and Patient Experience | Penn Medicine

On Thursday, April 23rd, C. William Hanson, MD, Chief Medical Information Officer and Mary Elizabeth Deleener, MBA, BSN, RN, Director of Network Telemedicine at Penn Medicine presented Best Practices for Telemedicine: The Provider and Patient Experience.

Lung Cancer During and After COVID-19 Video

Lung Cancer During and After COVID-19

Penn cancer specialists review decision-making for lung cancer patients in the context of COVID-19.

Featured Articles & Documents |view more

Neurogenetics Team Forms with "Tsunami" of Breakthroughs Looming News

Neurogenetics Team Forms with "Tsunami" of Breakthroughs Looming

The wealth of information that’s become available over the last 10 to 20 years coupled with the rapid evolution of the technology that can analyze it has dramatically transformed neurogenetics.

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases Document

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases

Surgeons and oncologists within the Department of Surgery at Penn Medicine are using adjuvant hepatic artery infusion chemotherapy with systemic chemotherapy to prevent recurrence in patients with resected colorectal liver metastases...

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer Document

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Investigators in the Division of Gynecologic Oncology at Penn Medicine are conducting a clinical trial to investigate combination therapy with olaparib and AZD6738 in women with high grade serous ovarian or primary peritoneal and/or fallopian tube cancer.

News Updates

New Cancer Immunotherapy Targeting Myeloid Cells Slows Tumor Growth

Tuesday, May 26, 2020 3:53 PM

Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.

Researchers Suggest Increased Risk of Respiratory-Tract Infections in People on Certain Psoriasis Treatment

Tuesday, May 26, 2020 10:39 AM

After examining data from large trials of autoimmune-disease medications called Interleukin-17 (IL-17) inhibitors, researchers at the Perelman School of Medicine at the University of Pennsylvania found individuals who took these treatments ...

New Liver Cancer Research Targets Non-Cancer Cells to Blunt Tumor Growth

Tuesday, May 19, 2020 4:47 PM

Senotherapy,” a treatment that uses small molecule drugs to target “senescent” cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste ...

View More

Physician Blog

SARS-CoV-2 Antibody Test at Penn Medicine

Monday, May 18, 2020 8:00 PM

Penn conducts COVID-19 antibody testing using an advanced chemoluminecent microparticle SARS-CoV-2 antibody immunoassay from Abbott Laboratories. Learn more about the intended uses and background of the Abbott immunoassay.

COVID-19 and Opioid Use Disorder

Monday, May 18, 2020 8:00 PM

Penn's Leonard Davis Institute of Health Economics explores how the COVID-19 pandemic has impacted opioid use disorder and overdose crisis.

Penn Task Force Offers Guidelines for Tracheostomy in Ventilated Patients with COVID19

Monday, May 4, 2020 8:00 PM

A task force from the Penn Airway Safety Committee has created Guidelines for the application of tracheostomy in COVID-19 patients.

View More

Penn Events

UPDATES IN ONCOLOGY 2020 PHILADELPHIA with Proceedings from International Medical Meetings - Virtual Meeting

Zoom platform - invitation link will be sent via email to registrants Thursday, June 18, 2020, 5 – 9:20pm Type of Event: CME Course, Conference Sponsor: Abramson Cancer Center Program Overview: This activity ...

PAYMENT FOR UPDATES IN ONCOLOGY 2020 VIRTUAL EXHIBIT

Zoom.us Thursday, June 18, 2020, 5 – 9:20pm For virtual exhibit payment ONLY.  Address: Zoom.us Type of Event: Other Sponsor: Abramson Cancer Center

Neuro-Oncology Brain Tumor Symposium 2020: Best Practices in Patient Care

Friday, October 30, 2020, 7am – 3:15pm Location: Jordan Medical Education Center Address: 3400 Civic Center Boulevard, Philadelphia PA, 19104 Type of Event: Conference Sponsor: Abramson Cancer Center ...

View More




Penn Medicine, Philadelphia, PA 800-789-7366 © , The Trustees of the University of Pennsylvania

Powered by the BroadcastMed Network